Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Southern Acids (M) Bhd's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was RM0.17.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.27.
During the past 12 months, Southern Acids (M) Bhd's average earnings per share (NRI) Growth Rate was 1.90% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 4.00% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -10.10% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Southern Acids (M) Bhd's EPS without NRI or its related term are showing as below:
XKLS:5134'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -28.4 Med: 4.35 Max: 63.8
Current: 4
During the past 13 years, Southern Acids (M) Bhd's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 63.80% per year. The lowest was -28.40% per year. And the median was 4.35% per year.
XKLS:5134's 3-Year EPS without NRI Growth Rate is ranked worse than 55.43% of 433
companies
in the Conglomerates industry
Industry Median: 7.9
vs XKLS:5134: 4.00
Southern Acids (M) Bhd (XKLS:5134) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Southern Acids (M) Bhd EPS without NRI Related Terms
Southern Acids (M) Bhd EPS without NRI Historical Data
* Premium members only.
The historical data trend for Southern Acids (M) Bhd's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Southern Acids (M) Bhd's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Southern Acids (M) Bhd PE Ratio without NRI vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Southern Acids (M) Bhd's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Southern Acids (M) Bhd's PE Ratio without NRI falls into.
Southern Acids (M) Bhd EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.27
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Southern Acids (M) Bhd (XKLS:5134) has a EPS without NRI of RM0.27 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Southern Acids (M) Bhd and its competitors. According to the industry distribution chart, Southern Acids (M) Bhd ranks #240 out of 433 companies in the Conglomerates industry, placing it in the top 55.4%.
Is Southern Acids (M) Bhd's EPS without NRI too high?
Southern Acids (M) Bhd's current EPS without NRI is RM0.27. Based on the distribution chart, Southern Acids (M) Bhd ranks #240 out of 433 companies in the Conglomerates industry, which is below the industry midpoint. Overall, Southern Acids (M) Bhd has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's EPS without NRI compare to HON and MMM?
According to the Conglomerates industry distribution chart, Southern Acids (M) Bhd ranks #240 out of 433 companies for EPS without NRI. This places Southern Acids (M) Bhd in the lower half of its industry. The industry median EPS without NRI is 7.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Conglomerates company?
The median EPS without NRI among Conglomerates companies is 7.90, based on 433 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Southern Acids (M) Bhd and its competitors. For the Conglomerates industry, the median EPS without NRI is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Southern Acids (M) Bhd's current EPS without NRI is RM0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.88, compared to a current price of RM3.05 — trading 5.9% above its estimated fair value. The current EPS without NRI is RM0.27. Southern Acids (M) Bhd's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current EPS without NRI is RM0.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?
Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued.
The current stock price of RM3.05 is trading 5.9% above its estimated GF Value™ of RM2.88.
GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.
Key valuation signals for XKLS:5134:
EPS without NRI: RM0.27
GF Value™: RM2.88 vs. price of RM3.05 (5.9% above fair value)
No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
72GF Score
Get the complete analysis for XKLS:5134
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5134 has been successfully added to your 
